This mechanism is well established in diseases such as myasthenia gravis and Lambert-Eaton myasthenic syndrome [30], and in CNS autoimmune diseases such as the anti-potassium channel antibody spectrum and paraneoplastic autoimmune diseases [31,32]. This evidence concerns the gene KCNA3 and Lambert-Eaton myasthenic syndrome.